CBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cabot Corp (CBT) is not a strong buy for a beginner, long-term investor at this time. The company's recent financial performance shows declining revenue, net income, and EPS, which raises concerns about its growth potential. Additionally, the technical indicators suggest a bearish trend despite a slight positive MACD. The options data indicates neutral to slightly positive sentiment, but there are no strong catalysts or recent news to drive significant upward momentum. Analysts are mixed, with some downgrades and cautious outlooks. For a long-term investor, it may be better to wait for clearer signs of recovery or stronger growth potential before investing.
The MACD is positive and expanding (0.452), indicating slight bullish momentum. However, the RSI at 76.511 is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near resistance levels (R2: 74.611), suggesting limited immediate upside potential.
Jefferies raised the price target to $81 and maintained a Buy rating after a multi-year supply agreement with Volkswagen's subsidiary PowerCo for EV battery production. This could support long-term growth in the EV sector.
Mizuho downgraded the stock to Neutral, citing weak demand for tire and rubber products and a lack of recovery in sight. Financial performance in Q1 2026 showed significant YoY declines in revenue (-11.10%), net income (-21.74%), and EPS (-18.56%).
In Q1 2026, revenue dropped to $849M (-11.10% YoY), net income dropped to $72M (-21.74% YoY), and EPS dropped to $1.36 (-18.56% YoY). Gross margin slightly improved to 24.85% (+0.98% YoY), but overall financial performance indicates a decline in profitability and growth.
Analysts are mixed. Deutsche Bank raised the price target to $80 but maintained a Hold rating. UBS raised the price target to $81 with a Neutral rating. Mizuho downgraded the stock to Neutral from Outperform, citing weak demand and a lack of recovery. Jefferies maintained a Buy rating with a price target of $81, citing a positive supply agreement with Volkswagen's subsidiary.
